Sector
DiversifiedOpen
₹16.62Prev. Close
₹16.95Turnover(Lac.)
₹0.07Day's High
₹16.62Day's Low
₹16.6252 Week's High
₹62.7152 Week's Low
₹14.05Book Value
₹11.88Face Value
₹10Mkt Cap (₹ Cr.)
75.68P/E
188.33EPS
0.09Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 49.66 | 35.77 | 34.23 | 34.23 |
Preference Capital | 0 | 9.25 | 0 | 0 |
Reserves | 4.86 | 6.13 | -10.05 | -14.28 |
Net Worth | 54.52 | 51.15 | 24.18 | 19.95 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 21 | 0.5 | 0 | 0 |
yoy growth (%) | 4,086.31 | 0 | 0 | 0 |
Raw materials | -15.75 | -0.49 | 0 | 0 |
As % of sales | 75.01 | 98.99 | 0 | 0 |
Employee costs | -5.71 | -0.03 | -0.03 | -0.03 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | -6.77 | -0.2 | -0.05 | -0.12 |
Depreciation | -0.4 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | -7.73 | 12.32 | -0.01 | 0 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 4,086.31 | 0 | 0 | 0 |
Op profit growth | 2,904.62 | -27.61 | 73.4 | 19.4 |
EBIT growth | 2,994.01 | 188.61 | -56.51 | 19.41 |
Net profit growth | 5,197.08 | 281.11 | -56.51 | 19.41 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 166.23 | 162.93 | 61.57 | 21.09 | 49.9 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 166.23 | 162.93 | 61.57 | 21.09 | 49.9 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.21 | 4.49 | 0.22 | 0.27 | 0.2 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
3M India Ltd 3MINDIA | 29,029.6 | 58.92 | 32,716.36 | 113.77 | 2.36 | 1,089.95 | 1,477.83 |
DCM Shriram Ltd DCMSHRIRAM | 993.55 | 27.35 | 15,493.65 | 174.69 | 0.91 | 2,778.11 | 450.21 |
Nava Ltd NAVA | 430.55 | 31.57 | 12,494.62 | 47.38 | 0.46 | 279.96 | 131.73 |
Swan Energy Ltd SWANENERGY | 391.1 | 0 | 12,259.3 | 1.57 | 0.03 | 28.14 | 145.64 |
Quess Corp Ltd QUESS | 329.2 | 10.44 | 4,903.41 | 99.68 | 3.03 | 4,707.64 | 190.49 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Kasiraman Sayee Sundar
Whole-time Director
Singarababu Indirakumar
Whole-time Director
Muthu Krishnan Ramesh
Independent Non Exe. Director
K S Vaidyanathan
Whole-time Director
G Swaminathan
Non-Exec & Non-Independent Dir
Lakshmi Prabha
Chairman & Independent Directo
N M Ranganathan
Independent Non Exe. Director
B N Padmaja Priyadarshini
Company Sec. & Compli. Officer
V Santhana Krishnan
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Indrayani Biotech Ltd
Summary
Indrayani Biotech Limited was incorporated in 1992. The Company came out with a public issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. Presently, the Company is engaged in manufacture of electric motors, generators, transformers and electricity distribution and control apparatusTechnical agreements have been signed with Floral Max, Malaysia; for rose cultivation; and with B L McKenzie and Associates, New Zealand, for tissue culture. The planting material for strawberries has been acquired from the US. The company has signed a test agreement with the Technology Transfer Offer of the University of California to obtain certified planting material from nurseries in California. IBL started exporting flowers to Holland and Dubai during 1994-95. Restricted water supply and changes in ecology resulted in a shortfall in achieving its goals.In 1995-96, the company incurred losses due to reasons beyond the control of the management like insufficient water supply, labour problem and sub-standard infrastructure. To overcome the above problems, the company is considering to shift its green houses to alternate locations.During the year 2010-11, the Scheme of Arrangement, seeking to reduce the equity share capital of the Company by 88%, conversion of unsecured loan into the equity shares, demerging the entire business into Indrayani Tissue Culture Pvt. Ltd., merging YoGoYo Division of Websource Technologies
Read More
The Indrayani Biotech Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹16.62 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indrayani Biotech Ltd is ₹75.68 Cr. as of 09 May ‘25
The PE and PB ratios of Indrayani Biotech Ltd is 188.33 and 1.43 as of 09 May ‘25
The 52-week high/low is the highest and lowest price at which a Indrayani Biotech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Indrayani Biotech Ltd is ₹14.05 and ₹62.71 as of 09 May ‘25
Indrayani Biotech Ltd's CAGR for 5 Years at 16.06%, 3 Years at -17.56%, 1 Year at -67.96%, 6 Month at -62.39%, 3 Month at -34.91% and 1 Month at -8.48%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.